BioSpace News Archive

Alafair Biosciences, Inc. announced that surgeons have implanted over 12,000 units of its flagship product, VersaWrap®, in patients since commercial launch.

Kiyatec is pleased to announce that Mark Capone, former CEO of Myriad Genetics, has joined its team as a strategic advisor.

FluoGuide A/S today announced that topline results from the phase IIa trial of its lead product FG001 in guiding surgery in patients with head & neck cancer, confirming positive efficacy and safety, were presented at the International Academy of Oral Oncology (IAOO) 2023 conference in Incheon, South Korea.

Throughout 2022, we deployed new staff training and development programs that are customer-centric and emphasize thoughtful and patient-focused care delivery.

Epic Bio announced a presentation at the upcoming CRISPR2.0 conference being held November 28-30, 2023, at the Hilton Boston Back Bay, Boston Massachusetts.

Oryzon Genomics, S.A. announced the entry into a new convertible bonds financing agreement with Nice & Green in bonds convertible into new shares for a total amount of €45 Million.

American Aires Inc. (CSE: WIFI) (OTC Pink: AAIRD) (“Aires” or the “Company”), a pioneer in EMF modulation technology, is pleased to announce filing of its unaudited Financial Statements and Management’s Discussion & Analysis (MD&A) for Q3/2023, spanning from July 1 to September 30, 2023.

Sana Biotechnology, Inc. today announced that it will webcast its presentations at two investor conferences in November and December.

Mercury Bio, (www.mercurybio.com) a Santa Fe, NM-based biotech company commercializing an innovative and highly disruptive drug delivery platform

Uncovering biological properties of extracellular vesicles, which play a vital role in how cells communicate, and understanding how sex hormones drive behavior and development are two areas that the new cohorts of Allen Distinguished Investigators will research, thanks to over $10 million in funding from the Paul G.